SCIENTURE HOLDINGS, INC. Revenue from Contract with Customer, Excluding Assessed Tax
SCIENTURE HOLDINGS, INC. (SCNX) reported Revenue from Contract with Customer, Excluding Assessed Tax of $343.64 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Revenue
us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax · last filed 2026-08-13
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-06-30 was $343.64K.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2026-03-31 was $56.33K, a 449.08% increase year-over-year.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-12-31 was -$168.70K, a 417.80% decline year-over-year.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for the quarter ending 2025-09-30 was $590.05K, a 809.71% increase year-over-year.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2025 was $431.61K, a 215.87% increase from fiscal 2024.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2024 was $136.64K, a 89.98% decline from fiscal 2023.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2023 was $1.36M, a 86.69% decline from fiscal 2022.
- SCIENTURE HOLDINGS, INC. revenue from contract with customer, excluding assessed tax for fiscal 2022 was $10.25M, a 3.65% increase from fiscal 2021.
| Period end | Revenue from Contract with Customer, Excluding Assessed Tax 3 month | Revenue from Contract with Customer, Excluding Assessed Tax 3 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 6 month | Revenue from Contract with Customer, Excluding Assessed Tax 6 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 9 month | Revenue from Contract with Customer, Excluding Assessed Tax 9 month as first filed | Revenue from Contract with Customer, Excluding Assessed Tax 12 month | Revenue from Contract with Customer, Excluding Assessed Tax 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $343.64K 10-Q · filed 2026-08-13 | $399.96K 10-Q · filed 2026-08-13 | $231.26K derived: sum of 3 quarters · filed 2026-08-13 | $821.32K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2026-03-31 | $56.33K 10-Q · filed 2026-05-15 | -$112.37K derived: sum of 2 quarters · filed 2026-05-15 | $477.68K derived: sum of 3 quarters · filed 2026-05-15 | $477.68K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-12-31 | -$168.70K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $421.35K derived: sum of 2 quarters · filed 2026-03-30 | $421.35K derived: sum of 3 quarters · filed 2026-08-13 | $431.61K 10-K · filed 2026-03-30 | ||||
| 2025-09-30 | $590.05K 10-Q · filed 2025-11-12 | $590.05K derived: sum of 2 quarters · filed 2026-08-13 | $600.31K 10-Q · filed 2025-11-12 | $653.39K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | $10.26K 10-Q · filed 2026-08-13 | $63.34K derived: sum of 3 quarters · filed 2026-08-13 | $128.20K derived: sum of 4 quarters · filed 2026-08-13 | ||||
| 2025-03-31 | $10.26K 10-Q · filed 2026-05-15 | $63.34K derived: sum of 2 quarters · filed 2026-05-15 | $128.20K derived: sum of 3 quarters · filed 2026-05-15 | $146.90K derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | $53.08K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $117.94K derived: sum of 2 quarters · filed 2026-03-30 | $136.64K derived: sum of 3 quarters · filed 2026-03-30 | $136.64K 10-K · filed 2026-03-30 | ||||
| 2024-09-30 | $64.86K 10-Q · filed 2025-11-12 | $83.56K derived: sum of 2 quarters · filed 2025-11-12 | $83.56K 10-Q · filed 2025-11-12 | |||||
| 2024-06-30 | $18.70K 10-Q · filed 2025-08-12 | $18.70K 10-Q · filed 2025-08-12 | ||||||
| 2023-12-31 | $128.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $520.95K derived: sum of 2 quarters · filed 2025-03-26 | $887.47K derived: sum of 3 quarters · filed 2025-03-26 | $1.36M 10-K · filed 2025-03-26 | $8.27M 10-K · filed 2024-04-22 | |||
| 2023-09-30 | $392.29K 10-Q · filed 2024-11-06 | $2.06M 10-Q · filed 2024-01-16 | $758.81K derived: sum of 2 quarters · filed 2024-11-06 | $1.24M 10-Q · filed 2024-11-06 | $5.92M 10-Q · filed 2024-01-16 | $3.51M derived: sum of 4 quarters · filed 2024-11-06 | ||
| 2023-06-30 | $366.53K 10-Q · filed 2024-08-09 | $2.25M 10-Q · filed 2023-08-18 | $842.88K 10-Q · filed 2024-08-09 | $4.50M 10-Q · filed 2023-08-18 | $3.12M derived: sum of 3 quarters · filed 2024-08-09 | $5.17M derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $493.32K 10-Q · filed 2024-06-26 | $2.25M 10-Q · filed 2023-05-15 | $2.75M derived: sum of 2 quarters · filed 2024-06-26 | $4.81M derived: sum of 3 quarters · filed 2024-06-26 | $8.08M derived: sum of 4 quarters · filed 2024-06-26 | |||
| 2022-12-31 | $2.26M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-22 | $4.31M derived: sum of 2 quarters · filed 2024-04-22 | $7.59M derived: sum of 3 quarters · filed 2024-04-22 | $10.25M 10-K · filed 2024-04-22 | $11.45M 10-K · filed 2023-03-27 | |||
| 2022-09-30 | $2.06M 10-Q · filed 2024-01-16 | $2.40M 10-Q · filed 2022-11-07 | $5.33M derived: sum of 2 quarters · filed 2024-01-16 | $7.99M 10-Q · filed 2024-01-16 | $8.92M 10-Q · filed 2022-11-07 | $10.96M derived: sum of 4 quarters · filed 2024-01-16 | ||
| 2022-06-30 | $3.28M 10-Q · filed 2023-08-18 | $6.52M 10-Q · filed 2023-08-18 | $8.91M derived: sum of 3 quarters · filed 2023-08-18 | $11.46M derived: sum of 4 quarters · filed 2023-08-18 | ||||
| 2022-03-31 | $3.24M 10-Q · filed 2023-05-15 | $5.63M derived: sum of 2 quarters · filed 2023-05-15 | $8.18M derived: sum of 3 quarters · filed 2023-05-15 | $10.08M derived: sum of 4 quarters · filed 2023-05-15 | ||||
| 2021-12-31 | $2.39M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $4.94M derived: sum of 2 quarters · filed 2023-03-27 | $6.84M derived: sum of 3 quarters · filed 2023-03-27 | $9.89M 10-K · filed 2023-03-27 | ||||
| 2021-09-30 | $2.55M 10-Q · filed 2022-11-07 | $4.45M derived: sum of 2 quarters · filed 2022-11-07 | $7.50M 10-Q · filed 2022-11-07 | $9.50M derived: sum of 4 quarters · filed 2022-11-07 | ||||
| 2021-06-30 | $1.90M 10-Q · filed 2022-07-25 | $4.95M 10-Q · filed 2022-07-25 | $6.95M derived: sum of 3 quarters · filed 2022-07-25 | $13.28M derived: sum of 4 quarters · filed 2022-07-25 | ||||
| 2021-03-31 | $3.05M 10-Q · filed 2022-05-09 | $5.05M derived: sum of 2 quarters · filed 2022-05-09 | $11.38M derived: sum of 3 quarters · filed 2022-05-09 | $17.97M derived: sum of 4 quarters · filed 2022-05-09 | ||||
| 2020-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $8.33M derived: sum of 2 quarters · filed 2022-03-28 | $14.92M derived: sum of 3 quarters · filed 2022-03-28 | $17.12M 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | $6.33M 10-Q · filed 2021-10-25 | $12.92M derived: sum of 2 quarters · filed 2021-10-25 | $15.13M 10-Q · filed 2021-10-25 | $16.82M derived: sum of 4 quarters · filed 2021-10-25 | ||||
| 2020-06-30 | $6.59M 10-Q · filed 2021-07-26 | $8.80M 10-Q · filed 2021-07-26 | $10.49M derived: sum of 3 quarters · filed 2021-07-26 | $12.80M derived: sum of 4 quarters · filed 2021-07-26 | ||||
| 2020-03-31 | $2.20M 10-Q · filed 2021-04-26 | $3.90M derived: sum of 2 quarters · filed 2021-04-26 | $6.21M derived: sum of 3 quarters · filed 2021-04-26 | $8.13M derived: sum of 4 quarters · filed 2021-04-26 | ||||
| 2019-12-31 | $1.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $4.01M derived: sum of 2 quarters · filed 2021-03-29 | $5.92M derived: sum of 3 quarters · filed 2021-03-29 | $7.44M 10-K · filed 2021-03-29 | ||||
| 2019-09-30 | $2.31M 10-Q · filed 2020-10-26 | $4.23M derived: sum of 2 quarters · filed 2020-10-26 | $5.74M 10-Q · filed 2020-10-26 | $7.03M derived: sum of 4 quarters · filed 2020-10-26 | ||||
| 2019-06-30 | $1.92M 10-Q · filed 2020-07-27 | $3.43M 10-Q · filed 2020-07-27 | $4.72M derived: sum of 3 quarters · filed 2020-07-27 | $5.57M derived: sum of 4 quarters · filed 2020-07-27 | ||||
| 2019-03-31 | $1.51M 10-Q · filed 2020-05-04 | $2.81M derived: sum of 2 quarters · filed 2020-05-04 | $3.65M derived: sum of 3 quarters · filed 2020-05-04 | $4.49M derived: sum of 4 quarters · filed 2020-05-04 | ||||
| 2018-12-31 | $1.29M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | $2.14M derived: sum of 2 quarters · filed 2020-03-30 | $2.98M derived: sum of 3 quarters · filed 2020-03-30 | $3.83M 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | $847.47K 10-Q · filed 2019-10-28 | $1.69M derived: sum of 2 quarters · filed 2019-10-28 | $2.54M 10-Q · filed 2019-10-28 | |||||
| 2018-06-30 | $837.69K 10-Q · filed 2019-07-26 | $1.69M 10-Q · filed 2019-07-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |